Hana Biosciences

Cancer drug development

Hana Biosciences, Inc. is a biopharmaceutical company dedicated to developing and commercializing new, differentiated cancer therapies designed to improve and enable current standards of care. The company’s lead product candidate, Marqibo(R),...

Total money raised: $100M

San Francisco
San Francisco
Updated on May 2, 2013
Hana Biosciences at CrunchBase
Mark Ahn President and CEO
Alex Tkachenko VP Corporate Development

June, 2010

Hana Biosciences raised $100M in unattributed round from Warburg Pincus and Deerfield Capital Management

Hana Biosciences Announces Financing of Up to $100 Million